nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2B—Raloxifene—osteoporosis	0.473	1	CbGbCtD
Amisulpride—Sulpiride—CA2—osteoporosis	0.00788	1	CrCbGaD
Amisulpride—Nervousness—Pamidronate—osteoporosis	0.000999	0.00201	CcSEcCtD
Amisulpride—Somnolence—Estropipate—osteoporosis	0.000993	0.002	CcSEcCtD
Amisulpride—Muscle spasms—Pamidronate—osteoporosis	0.000989	0.00199	CcSEcCtD
Amisulpride—Angioedema—Risedronate—osteoporosis	0.000989	0.00199	CcSEcCtD
Amisulpride—Dyspepsia—Estropipate—osteoporosis	0.000984	0.00198	CcSEcCtD
Amisulpride—Angiopathy—Zoledronate—osteoporosis	0.000979	0.00197	CcSEcCtD
Amisulpride—Insomnia—Raloxifene—osteoporosis	0.000979	0.00197	CcSEcCtD
Amisulpride—Immune system disorder—Zoledronate—osteoporosis	0.000975	0.00196	CcSEcCtD
Amisulpride—Insomnia—Ibandronate—osteoporosis	0.000969	0.00195	CcSEcCtD
Amisulpride—Dyspepsia—Alendronate—osteoporosis	0.000969	0.00195	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Estropipate—osteoporosis	0.000965	0.00194	CcSEcCtD
Amisulpride—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000964	0.00194	CcSEcCtD
Amisulpride—Fatigue—Estropipate—osteoporosis	0.000963	0.00194	CcSEcCtD
Amisulpride—Constipation—Estropipate—osteoporosis	0.000955	0.00192	CcSEcCtD
Amisulpride—Dyspepsia—Raloxifene—osteoporosis	0.000953	0.00192	CcSEcCtD
Amisulpride—Hypersensitivity—Etidronic acid—osteoporosis	0.000952	0.00191	CcSEcCtD
Amisulpride—Insomnia—Calcitriol—osteoporosis	0.000949	0.00191	CcSEcCtD
Amisulpride—Weight increased—Estradiol—osteoporosis	0.000946	0.0019	CcSEcCtD
Amisulpride—Mental disorder—Zoledronate—osteoporosis	0.000946	0.0019	CcSEcCtD
Amisulpride—Agitation—Pamidronate—osteoporosis	0.000945	0.0019	CcSEcCtD
Amisulpride—Dyspepsia—Ibandronate—osteoporosis	0.000943	0.0019	CcSEcCtD
Amisulpride—Angiopathy—Conjugated Estrogens—osteoporosis	0.000943	0.0019	CcSEcCtD
Amisulpride—Anxiety—Ethinyl Estradiol—osteoporosis	0.000941	0.00189	CcSEcCtD
Amisulpride—Constipation—Alendronate—osteoporosis	0.000941	0.00189	CcSEcCtD
Amisulpride—Weight decreased—Estradiol—osteoporosis	0.00094	0.00189	CcSEcCtD
Amisulpride—Angioedema—Pamidronate—osteoporosis	0.00094	0.00189	CcSEcCtD
Amisulpride—Malnutrition—Zoledronate—osteoporosis	0.000939	0.00189	CcSEcCtD
Amisulpride—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000939	0.00189	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000938	0.00189	CcSEcCtD
Amisulpride—Hyperglycaemia—Estradiol—osteoporosis	0.000937	0.00189	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000934	0.00188	CcSEcCtD
Amisulpride—Hypertension—Risedronate—osteoporosis	0.000934	0.00188	CcSEcCtD
Amisulpride—Somnolence—Calcitriol—osteoporosis	0.000932	0.00188	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000925	0.00186	CcSEcCtD
Amisulpride—Depression—Estradiol—osteoporosis	0.000924	0.00186	CcSEcCtD
Amisulpride—Fatigue—Ibandronate—osteoporosis	0.000924	0.00186	CcSEcCtD
Amisulpride—Leukopenia—Pamidronate—osteoporosis	0.000921	0.00185	CcSEcCtD
Amisulpride—Anxiety—Risedronate—osteoporosis	0.000918	0.00185	CcSEcCtD
Amisulpride—Constipation—Ibandronate—osteoporosis	0.000916	0.00184	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000915	0.00184	CcSEcCtD
Amisulpride—Pruritus—Etidronic acid—osteoporosis	0.000914	0.00184	CcSEcCtD
Amisulpride—Gastrointestinal pain—Estropipate—osteoporosis	0.000914	0.00184	CcSEcCtD
Amisulpride—Mental disorder—Conjugated Estrogens—osteoporosis	0.00091	0.00183	CcSEcCtD
Amisulpride—Neuropathy peripheral—Estradiol—osteoporosis	0.000908	0.00183	CcSEcCtD
Amisulpride—Malnutrition—Conjugated Estrogens—osteoporosis	0.000905	0.00182	CcSEcCtD
Amisulpride—Muscle spasms—Zoledronate—osteoporosis	0.000903	0.00182	CcSEcCtD
Amisulpride—Dry mouth—Risedronate—osteoporosis	0.000901	0.00181	CcSEcCtD
Amisulpride—Gastrointestinal pain—Alendronate—osteoporosis	0.0009	0.00181	CcSEcCtD
Amisulpride—Constipation—Calcitriol—osteoporosis	0.000897	0.0018	CcSEcCtD
Amisulpride—Convulsion—Pamidronate—osteoporosis	0.000891	0.00179	CcSEcCtD
Amisulpride—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000888	0.00179	CcSEcCtD
Amisulpride—Hypertension—Pamidronate—osteoporosis	0.000888	0.00179	CcSEcCtD
Amisulpride—Tension—Conjugated Estrogens—osteoporosis	0.000888	0.00179	CcSEcCtD
Amisulpride—Urticaria—Estropipate—osteoporosis	0.000888	0.00179	CcSEcCtD
Amisulpride—Gastrointestinal pain—Raloxifene—osteoporosis	0.000885	0.00178	CcSEcCtD
Amisulpride—Diarrhoea—Etidronic acid—osteoporosis	0.000884	0.00178	CcSEcCtD
Amisulpride—Abdominal pain—Estropipate—osteoporosis	0.000883	0.00178	CcSEcCtD
Amisulpride—Tremor—Zoledronate—osteoporosis	0.00088	0.00177	CcSEcCtD
Amisulpride—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00088	0.00177	CcSEcCtD
Amisulpride—Nervousness—Conjugated Estrogens—osteoporosis	0.000879	0.00177	CcSEcCtD
Amisulpride—Gastrointestinal pain—Ibandronate—osteoporosis	0.000876	0.00176	CcSEcCtD
Amisulpride—Urticaria—Alendronate—osteoporosis	0.000874	0.00176	CcSEcCtD
Amisulpride—Anxiety—Pamidronate—osteoporosis	0.000873	0.00176	CcSEcCtD
Amisulpride—Abdominal pain—Alendronate—osteoporosis	0.00087	0.00175	CcSEcCtD
Amisulpride—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00087	0.00175	CcSEcCtD
Amisulpride—Nervous system disorder—Risedronate—osteoporosis	0.000866	0.00174	CcSEcCtD
Amisulpride—Agitation—Zoledronate—osteoporosis	0.000863	0.00174	CcSEcCtD
Amisulpride—Angioedema—Zoledronate—osteoporosis	0.000858	0.00173	CcSEcCtD
Amisulpride—Skin disorder—Risedronate—osteoporosis	0.000858	0.00173	CcSEcCtD
Amisulpride—Gastrointestinal pain—Calcitriol—osteoporosis	0.000858	0.00173	CcSEcCtD
Amisulpride—Abdominal pain—Raloxifene—osteoporosis	0.000856	0.00172	CcSEcCtD
Amisulpride—Urticaria—Ibandronate—osteoporosis	0.000851	0.00171	CcSEcCtD
Amisulpride—Abdominal pain—Ibandronate—osteoporosis	0.000847	0.0017	CcSEcCtD
Amisulpride—Leukopenia—Zoledronate—osteoporosis	0.000841	0.00169	CcSEcCtD
Amisulpride—Urticaria—Calcitriol—osteoporosis	0.000833	0.00168	CcSEcCtD
Amisulpride—Abdominal pain—Calcitriol—osteoporosis	0.000829	0.00167	CcSEcCtD
Amisulpride—Angioedema—Conjugated Estrogens—osteoporosis	0.000827	0.00166	CcSEcCtD
Amisulpride—Hypersensitivity—Estropipate—osteoporosis	0.000823	0.00166	CcSEcCtD
Amisulpride—Nervous system disorder—Pamidronate—osteoporosis	0.000823	0.00166	CcSEcCtD
Amisulpride—Vomiting—Etidronic acid—osteoporosis	0.000821	0.00165	CcSEcCtD
Amisulpride—Convulsion—Zoledronate—osteoporosis	0.000814	0.00164	CcSEcCtD
Amisulpride—Hyperhidrosis—Pamidronate—osteoporosis	0.000811	0.00163	CcSEcCtD
Amisulpride—Hypertension—Zoledronate—osteoporosis	0.000811	0.00163	CcSEcCtD
Amisulpride—Hypersensitivity—Alendronate—osteoporosis	0.000811	0.00163	CcSEcCtD
Amisulpride—Headache—Etidronic acid—osteoporosis	0.000809	0.00163	CcSEcCtD
Amisulpride—Asthenia—Estropipate—osteoporosis	0.000802	0.00161	CcSEcCtD
Amisulpride—Insomnia—Risedronate—osteoporosis	0.000799	0.00161	CcSEcCtD
Amisulpride—Anxiety—Zoledronate—osteoporosis	0.000797	0.0016	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000794	0.0016	CcSEcCtD
Amisulpride—Pruritus—Estropipate—osteoporosis	0.000791	0.00159	CcSEcCtD
Amisulpride—Asthenia—Alendronate—osteoporosis	0.00079	0.00159	CcSEcCtD
Amisulpride—Hypersensitivity—Ibandronate—osteoporosis	0.000789	0.00159	CcSEcCtD
Amisulpride—Hypotension—Pamidronate—osteoporosis	0.000784	0.00158	CcSEcCtD
Amisulpride—Convulsion—Conjugated Estrogens—osteoporosis	0.000784	0.00158	CcSEcCtD
Amisulpride—Dry mouth—Zoledronate—osteoporosis	0.000782	0.00157	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000782	0.00157	CcSEcCtD
Amisulpride—Fatigue—Ethinyl Estradiol—osteoporosis	0.000781	0.00157	CcSEcCtD
Amisulpride—Pruritus—Alendronate—osteoporosis	0.000779	0.00157	CcSEcCtD
Amisulpride—Dyspepsia—Risedronate—osteoporosis	0.000777	0.00156	CcSEcCtD
Amisulpride—Constipation—Ethinyl Estradiol—osteoporosis	0.000774	0.00156	CcSEcCtD
Amisulpride—Hypersensitivity—Calcitriol—osteoporosis	0.000773	0.00155	CcSEcCtD
Amisulpride—Cardiac disorder—Estradiol—osteoporosis	0.000772	0.00155	CcSEcCtD
Amisulpride—Asthenia—Ibandronate—osteoporosis	0.000769	0.00155	CcSEcCtD
Amisulpride—Anxiety—Conjugated Estrogens—osteoporosis	0.000767	0.00154	CcSEcCtD
Amisulpride—Nausea—Etidronic acid—osteoporosis	0.000767	0.00154	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000765	0.00154	CcSEcCtD
Amisulpride—Diarrhoea—Estropipate—osteoporosis	0.000764	0.00154	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Risedronate—osteoporosis	0.000762	0.00153	CcSEcCtD
Amisulpride—Fatigue—Risedronate—osteoporosis	0.000761	0.00153	CcSEcCtD
Amisulpride—Insomnia—Pamidronate—osteoporosis	0.000759	0.00153	CcSEcCtD
Amisulpride—Pruritus—Ibandronate—osteoporosis	0.000758	0.00153	CcSEcCtD
Amisulpride—Constipation—Risedronate—osteoporosis	0.000755	0.00152	CcSEcCtD
Amisulpride—Angiopathy—Estradiol—osteoporosis	0.000755	0.00152	CcSEcCtD
Amisulpride—Diarrhoea—Alendronate—osteoporosis	0.000753	0.00152	CcSEcCtD
Amisulpride—Asthenia—Calcitriol—osteoporosis	0.000753	0.00151	CcSEcCtD
Amisulpride—Nervous system disorder—Zoledronate—osteoporosis	0.000752	0.00151	CcSEcCtD
Amisulpride—Immune system disorder—Estradiol—osteoporosis	0.000751	0.00151	CcSEcCtD
Amisulpride—Somnolence—Pamidronate—osteoporosis	0.000746	0.0015	CcSEcCtD
Amisulpride—Skin disorder—Zoledronate—osteoporosis	0.000745	0.0015	CcSEcCtD
Amisulpride—Pruritus—Calcitriol—osteoporosis	0.000742	0.00149	CcSEcCtD
Amisulpride—Hyperhidrosis—Zoledronate—osteoporosis	0.000741	0.00149	CcSEcCtD
Amisulpride—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000741	0.00149	CcSEcCtD
Amisulpride—Diarrhoea—Raloxifene—osteoporosis	0.000741	0.00149	CcSEcCtD
Amisulpride—Dyspepsia—Pamidronate—osteoporosis	0.000739	0.00149	CcSEcCtD
Amisulpride—Dizziness—Estropipate—osteoporosis	0.000739	0.00149	CcSEcCtD
Amisulpride—Diarrhoea—Ibandronate—osteoporosis	0.000733	0.00148	CcSEcCtD
Amisulpride—Mental disorder—Estradiol—osteoporosis	0.000729	0.00147	CcSEcCtD
Amisulpride—Dizziness—Alendronate—osteoporosis	0.000728	0.00146	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000725	0.00146	CcSEcCtD
Amisulpride—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000724	0.00146	CcSEcCtD
Amisulpride—Malnutrition—Estradiol—osteoporosis	0.000724	0.00146	CcSEcCtD
Amisulpride—Fatigue—Pamidronate—osteoporosis	0.000724	0.00146	CcSEcCtD
Amisulpride—Gastrointestinal pain—Risedronate—osteoporosis	0.000722	0.00145	CcSEcCtD
Amisulpride—Urticaria—Ethinyl Estradiol—osteoporosis	0.000719	0.00145	CcSEcCtD
Amisulpride—Constipation—Pamidronate—osteoporosis	0.000718	0.00144	CcSEcCtD
Amisulpride—Diarrhoea—Calcitriol—osteoporosis	0.000718	0.00144	CcSEcCtD
Amisulpride—Skin disorder—Conjugated Estrogens—osteoporosis	0.000717	0.00144	CcSEcCtD
Amisulpride—Hypotension—Zoledronate—osteoporosis	0.000716	0.00144	CcSEcCtD
Amisulpride—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000716	0.00144	CcSEcCtD
Amisulpride—Dizziness—Raloxifene—osteoporosis	0.000716	0.00144	CcSEcCtD
Amisulpride—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000714	0.00144	CcSEcCtD
Amisulpride—Tension—Estradiol—osteoporosis	0.00071	0.00143	CcSEcCtD
Amisulpride—Vomiting—Estropipate—osteoporosis	0.00071	0.00143	CcSEcCtD
Amisulpride—Dizziness—Ibandronate—osteoporosis	0.000709	0.00143	CcSEcCtD
Amisulpride—Nervousness—Estradiol—osteoporosis	0.000703	0.00141	CcSEcCtD
Amisulpride—Urticaria—Risedronate—osteoporosis	0.000701	0.00141	CcSEcCtD
Amisulpride—Headache—Estropipate—osteoporosis	0.0007	0.00141	CcSEcCtD
Amisulpride—Vomiting—Alendronate—osteoporosis	0.0007	0.00141	CcSEcCtD
Amisulpride—Abdominal pain—Risedronate—osteoporosis	0.000698	0.0014	CcSEcCtD
Amisulpride—Muscle spasms—Estradiol—osteoporosis	0.000696	0.0014	CcSEcCtD
Amisulpride—Insomnia—Zoledronate—osteoporosis	0.000693	0.0014	CcSEcCtD
Amisulpride—Hypotension—Conjugated Estrogens—osteoporosis	0.00069	0.00139	CcSEcCtD
Amisulpride—Headache—Alendronate—osteoporosis	0.000689	0.00139	CcSEcCtD
Amisulpride—Vomiting—Raloxifene—osteoporosis	0.000688	0.00138	CcSEcCtD
Amisulpride—Gastrointestinal pain—Pamidronate—osteoporosis	0.000686	0.00138	CcSEcCtD
Amisulpride—Somnolence—Zoledronate—osteoporosis	0.000682	0.00137	CcSEcCtD
Amisulpride—Vomiting—Ibandronate—osteoporosis	0.000681	0.00137	CcSEcCtD
Amisulpride—Tremor—Estradiol—osteoporosis	0.000678	0.00136	CcSEcCtD
Amisulpride—Headache—Raloxifene—osteoporosis	0.000678	0.00136	CcSEcCtD
Amisulpride—Dyspepsia—Zoledronate—osteoporosis	0.000675	0.00136	CcSEcCtD
Amisulpride—Headache—Ibandronate—osteoporosis	0.000671	0.00135	CcSEcCtD
Amisulpride—Insomnia—Conjugated Estrogens—osteoporosis	0.000668	0.00134	CcSEcCtD
Amisulpride—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000667	0.00134	CcSEcCtD
Amisulpride—Vomiting—Calcitriol—osteoporosis	0.000667	0.00134	CcSEcCtD
Amisulpride—Agitation—Estradiol—osteoporosis	0.000665	0.00134	CcSEcCtD
Amisulpride—Nausea—Estropipate—osteoporosis	0.000664	0.00134	CcSEcCtD
Amisulpride—Abdominal pain—Pamidronate—osteoporosis	0.000664	0.00134	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000662	0.00133	CcSEcCtD
Amisulpride—Angioedema—Estradiol—osteoporosis	0.000662	0.00133	CcSEcCtD
Amisulpride—Fatigue—Zoledronate—osteoporosis	0.000661	0.00133	CcSEcCtD
Amisulpride—Headache—Calcitriol—osteoporosis	0.000657	0.00132	CcSEcCtD
Amisulpride—Somnolence—Conjugated Estrogens—osteoporosis	0.000656	0.00132	CcSEcCtD
Amisulpride—Constipation—Zoledronate—osteoporosis	0.000656	0.00132	CcSEcCtD
Amisulpride—Nausea—Alendronate—osteoporosis	0.000654	0.00132	CcSEcCtD
Amisulpride—Hypersensitivity—Risedronate—osteoporosis	0.000651	0.00131	CcSEcCtD
Amisulpride—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00065	0.00131	CcSEcCtD
Amisulpride—Asthenia—Ethinyl Estradiol—osteoporosis	0.00065	0.00131	CcSEcCtD
Amisulpride—Nausea—Raloxifene—osteoporosis	0.000643	0.00129	CcSEcCtD
Amisulpride—Pruritus—Ethinyl Estradiol—osteoporosis	0.000641	0.00129	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000637	0.00128	CcSEcCtD
Amisulpride—Fatigue—Conjugated Estrogens—osteoporosis	0.000637	0.00128	CcSEcCtD
Amisulpride—Nausea—Ibandronate—osteoporosis	0.000636	0.00128	CcSEcCtD
Amisulpride—Asthenia—Risedronate—osteoporosis	0.000634	0.00127	CcSEcCtD
Amisulpride—Constipation—Conjugated Estrogens—osteoporosis	0.000631	0.00127	CcSEcCtD
Amisulpride—Gastrointestinal pain—Zoledronate—osteoporosis	0.000627	0.00126	CcSEcCtD
Amisulpride—Hypertension—Estradiol—osteoporosis	0.000625	0.00126	CcSEcCtD
Amisulpride—Pruritus—Risedronate—osteoporosis	0.000625	0.00126	CcSEcCtD
Amisulpride—Nausea—Calcitriol—osteoporosis	0.000623	0.00125	CcSEcCtD
Amisulpride—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00062	0.00125	CcSEcCtD
Amisulpride—Hypersensitivity—Pamidronate—osteoporosis	0.000618	0.00124	CcSEcCtD
Amisulpride—Anxiety—Estradiol—osteoporosis	0.000614	0.00124	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000612	0.00123	CcSEcCtD
Amisulpride—Urticaria—Zoledronate—osteoporosis	0.000609	0.00123	CcSEcCtD
Amisulpride—Abdominal pain—Zoledronate—osteoporosis	0.000606	0.00122	CcSEcCtD
Amisulpride—Diarrhoea—Risedronate—osteoporosis	0.000604	0.00122	CcSEcCtD
Amisulpride—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000604	0.00121	CcSEcCtD
Amisulpride—Dry mouth—Estradiol—osteoporosis	0.000603	0.00121	CcSEcCtD
Amisulpride—Asthenia—Pamidronate—osteoporosis	0.000602	0.00121	CcSEcCtD
Amisulpride—Dizziness—Ethinyl Estradiol—osteoporosis	0.000599	0.00121	CcSEcCtD
Amisulpride—Pruritus—Pamidronate—osteoporosis	0.000594	0.0012	CcSEcCtD
Amisulpride—Urticaria—Conjugated Estrogens—osteoporosis	0.000587	0.00118	CcSEcCtD
Amisulpride—Dizziness—Risedronate—osteoporosis	0.000584	0.00117	CcSEcCtD
Amisulpride—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000584	0.00117	CcSEcCtD
Amisulpride—Nervous system disorder—Estradiol—osteoporosis	0.000579	0.00117	CcSEcCtD
Amisulpride—Vomiting—Ethinyl Estradiol—osteoporosis	0.000576	0.00116	CcSEcCtD
Amisulpride—Diarrhoea—Pamidronate—osteoporosis	0.000574	0.00116	CcSEcCtD
Amisulpride—Skin disorder—Estradiol—osteoporosis	0.000574	0.00115	CcSEcCtD
Amisulpride—Hyperhidrosis—Estradiol—osteoporosis	0.000571	0.00115	CcSEcCtD
Amisulpride—Headache—Ethinyl Estradiol—osteoporosis	0.000567	0.00114	CcSEcCtD
Amisulpride—Hypersensitivity—Zoledronate—osteoporosis	0.000565	0.00114	CcSEcCtD
Amisulpride—Vomiting—Risedronate—osteoporosis	0.000561	0.00113	CcSEcCtD
Amisulpride—Dizziness—Pamidronate—osteoporosis	0.000555	0.00112	CcSEcCtD
Amisulpride—Headache—Risedronate—osteoporosis	0.000553	0.00111	CcSEcCtD
Amisulpride—Asthenia—Zoledronate—osteoporosis	0.00055	0.00111	CcSEcCtD
Amisulpride—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000544	0.00109	CcSEcCtD
Amisulpride—Pruritus—Zoledronate—osteoporosis	0.000542	0.00109	CcSEcCtD
Amisulpride—Nausea—Ethinyl Estradiol—osteoporosis	0.000538	0.00108	CcSEcCtD
Amisulpride—Insomnia—Estradiol—osteoporosis	0.000534	0.00108	CcSEcCtD
Amisulpride—Vomiting—Pamidronate—osteoporosis	0.000534	0.00107	CcSEcCtD
Amisulpride—Asthenia—Conjugated Estrogens—osteoporosis	0.00053	0.00107	CcSEcCtD
Amisulpride—Headache—Pamidronate—osteoporosis	0.000526	0.00106	CcSEcCtD
Amisulpride—Somnolence—Estradiol—osteoporosis	0.000525	0.00106	CcSEcCtD
Amisulpride—Diarrhoea—Zoledronate—osteoporosis	0.000525	0.00106	CcSEcCtD
Amisulpride—Nausea—Risedronate—osteoporosis	0.000525	0.00106	CcSEcCtD
Amisulpride—Pruritus—Conjugated Estrogens—osteoporosis	0.000522	0.00105	CcSEcCtD
Amisulpride—Dyspepsia—Estradiol—osteoporosis	0.00052	0.00105	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Estradiol—osteoporosis	0.00051	0.00103	CcSEcCtD
Amisulpride—Fatigue—Estradiol—osteoporosis	0.000509	0.00103	CcSEcCtD
Amisulpride—Dizziness—Zoledronate—osteoporosis	0.000507	0.00102	CcSEcCtD
Amisulpride—Constipation—Estradiol—osteoporosis	0.000505	0.00102	CcSEcCtD
Amisulpride—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000505	0.00102	CcSEcCtD
Amisulpride—Nausea—Pamidronate—osteoporosis	0.000499	0.001	CcSEcCtD
Amisulpride—Dizziness—Conjugated Estrogens—osteoporosis	0.000488	0.000982	CcSEcCtD
Amisulpride—Vomiting—Zoledronate—osteoporosis	0.000488	0.000981	CcSEcCtD
Amisulpride—Gastrointestinal pain—Estradiol—osteoporosis	0.000483	0.000972	CcSEcCtD
Amisulpride—Headache—Zoledronate—osteoporosis	0.00048	0.000967	CcSEcCtD
Amisulpride—Vomiting—Conjugated Estrogens—osteoporosis	0.000469	0.000945	CcSEcCtD
Amisulpride—Urticaria—Estradiol—osteoporosis	0.000469	0.000945	CcSEcCtD
Amisulpride—Abdominal pain—Estradiol—osteoporosis	0.000467	0.00094	CcSEcCtD
Amisulpride—Headache—Conjugated Estrogens—osteoporosis	0.000463	0.000931	CcSEcCtD
Amisulpride—Nausea—Zoledronate—osteoporosis	0.000455	0.000916	CcSEcCtD
Amisulpride—Nausea—Conjugated Estrogens—osteoporosis	0.000439	0.000882	CcSEcCtD
Amisulpride—Hypersensitivity—Estradiol—osteoporosis	0.000435	0.000876	CcSEcCtD
Amisulpride—Asthenia—Estradiol—osteoporosis	0.000424	0.000853	CcSEcCtD
Amisulpride—Pruritus—Estradiol—osteoporosis	0.000418	0.000841	CcSEcCtD
Amisulpride—Diarrhoea—Estradiol—osteoporosis	0.000404	0.000814	CcSEcCtD
Amisulpride—Dizziness—Estradiol—osteoporosis	0.000391	0.000786	CcSEcCtD
Amisulpride—Vomiting—Estradiol—osteoporosis	0.000376	0.000756	CcSEcCtD
Amisulpride—Headache—Estradiol—osteoporosis	0.00037	0.000745	CcSEcCtD
Amisulpride—Nausea—Estradiol—osteoporosis	0.000351	0.000706	CcSEcCtD
Amisulpride—DRD2—GPCR ligand binding—CALCA—osteoporosis	5.24e-05	0.00237	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—WNT1—osteoporosis	5.19e-05	0.00235	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PTH—osteoporosis	5.17e-05	0.00235	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CNR2—osteoporosis	5.17e-05	0.00234	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PTHLH—osteoporosis	5.17e-05	0.00234	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CALCA—osteoporosis	5.15e-05	0.00234	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MGLL—osteoporosis	5.06e-05	0.00229	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	5.05e-05	0.00229	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CNR2—osteoporosis	5.04e-05	0.00229	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—LRP5—osteoporosis	4.94e-05	0.00224	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PTH—osteoporosis	4.81e-05	0.00218	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—WNT1—osteoporosis	4.74e-05	0.00215	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—LRP6—osteoporosis	4.72e-05	0.00214	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PTHLH—osteoporosis	4.72e-05	0.00214	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	4.7e-05	0.00213	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CNR2—osteoporosis	4.69e-05	0.00213	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PTHLH—osteoporosis	4.69e-05	0.00213	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	4.66e-05	0.00211	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MGLL—osteoporosis	4.62e-05	0.0021	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—IL1B—osteoporosis	4.59e-05	0.00208	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SOST—osteoporosis	4.58e-05	0.00208	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CALCA—osteoporosis	4.55e-05	0.00206	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—POMC—osteoporosis	4.53e-05	0.00205	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LRP5—osteoporosis	4.51e-05	0.00204	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SOST—osteoporosis	4.51e-05	0.00204	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—WNT1—osteoporosis	4.41e-05	0.002	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PTHLH—osteoporosis	4.39e-05	0.00199	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LRP6—osteoporosis	4.32e-05	0.00196	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MGLL—osteoporosis	4.3e-05	0.00195	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PTHLH—osteoporosis	4.29e-05	0.00194	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—POMC—osteoporosis	4.21e-05	0.00191	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LRP5—osteoporosis	4.2e-05	0.0019	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CALCA—osteoporosis	4.16e-05	0.00188	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CALCR—osteoporosis	4.14e-05	0.00188	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTH1R—osteoporosis	4.14e-05	0.00188	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CALCA—osteoporosis	4.13e-05	0.00187	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTH1R—osteoporosis	4.08e-05	0.00185	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CALCR—osteoporosis	4.08e-05	0.00185	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PTH—osteoporosis	4.06e-05	0.00184	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LRP6—osteoporosis	4.02e-05	0.00182	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PTH—osteoporosis	3.99e-05	0.00181	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PTHLH—osteoporosis	3.99e-05	0.00181	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TLN1—osteoporosis	3.99e-05	0.00181	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CNR2—osteoporosis	3.95e-05	0.00179	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CNR2—osteoporosis	3.89e-05	0.00176	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CALCA—osteoporosis	3.87e-05	0.00175	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—POMC—osteoporosis	3.85e-05	0.00174	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CALCA—osteoporosis	3.77e-05	0.00171	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PTH—osteoporosis	3.68e-05	0.00167	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TLN1—osteoporosis	3.64e-05	0.00165	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PTH—osteoporosis	3.62e-05	0.00164	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.6e-05	0.00163	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CNR2—osteoporosis	3.59e-05	0.00163	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—POMC—osteoporosis	3.58e-05	0.00162	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	3.54e-05	0.0016	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CNR2—osteoporosis	3.53e-05	0.0016	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CALCA—osteoporosis	3.51e-05	0.00159	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—P4HB—osteoporosis	3.44e-05	0.00156	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—IL6—osteoporosis	3.42e-05	0.00155	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TLN1—osteoporosis	3.39e-05	0.00154	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—WNT1—osteoporosis	3.38e-05	0.00153	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PTHLH—osteoporosis	3.36e-05	0.00152	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTH—osteoporosis	3.34e-05	0.00152	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—TNF—osteoporosis	3.33e-05	0.00151	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—WNT1—osteoporosis	3.32e-05	0.00151	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PTHLH—osteoporosis	3.31e-05	0.0015	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MGLL—osteoporosis	3.29e-05	0.00149	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RAP1A—osteoporosis	3.29e-05	0.00149	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CNR2—osteoporosis	3.26e-05	0.00148	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MGLL—osteoporosis	3.24e-05	0.00147	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—ADCY5—osteoporosis	3.24e-05	0.00147	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LRP5—osteoporosis	3.21e-05	0.00146	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NFATC1—osteoporosis	3.21e-05	0.00145	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DKK1—osteoporosis	3.18e-05	0.00144	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LRP5—osteoporosis	3.16e-05	0.00143	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—P4HB—osteoporosis	3.14e-05	0.00142	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LRP6—osteoporosis	3.07e-05	0.00139	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—WNT1—osteoporosis	3.06e-05	0.00139	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTH—osteoporosis	3.06e-05	0.00139	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PTHLH—osteoporosis	3.05e-05	0.00138	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LRP6—osteoporosis	3.02e-05	0.00137	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RAP1A—osteoporosis	3e-05	0.00136	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PTHLH—osteoporosis	3e-05	0.00136	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGA—osteoporosis	2.98e-05	0.00135	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CNR2—osteoporosis	2.98e-05	0.00135	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.97e-05	0.00134	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CALCA—osteoporosis	2.96e-05	0.00134	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—ADCY5—osteoporosis	2.96e-05	0.00134	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—ADCY5—osteoporosis	2.94e-05	0.00133	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NFATC1—osteoporosis	2.93e-05	0.00133	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—P4HB—osteoporosis	2.92e-05	0.00133	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—IL6—osteoporosis	2.91e-05	0.00132	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CALCA—osteoporosis	2.91e-05	0.00132	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DKK1—osteoporosis	2.91e-05	0.00132	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTH—osteoporosis	2.84e-05	0.00129	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—WNT1—osteoporosis	2.8e-05	0.00127	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RAP1A—osteoporosis	2.8e-05	0.00127	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CNR2—osteoporosis	2.77e-05	0.00126	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—BMP2—osteoporosis	2.77e-05	0.00126	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTHLH—osteoporosis	2.77e-05	0.00126	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—ADCY5—osteoporosis	2.75e-05	0.00125	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—POMC—osteoporosis	2.74e-05	0.00124	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NFATC1—osteoporosis	2.73e-05	0.00124	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGA—osteoporosis	2.72e-05	0.00123	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGB—osteoporosis	2.71e-05	0.00123	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—DKK1—osteoporosis	2.71e-05	0.00123	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—POMC—osteoporosis	2.7e-05	0.00122	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CALCA—osteoporosis	2.69e-05	0.00122	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—IL6—osteoporosis	2.69e-05	0.00122	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—ADCY5—osteoporosis	2.68e-05	0.00122	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CALCA—osteoporosis	2.64e-05	0.0012	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PSMA5—osteoporosis	2.62e-05	0.00119	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PSMA2—osteoporosis	2.62e-05	0.00119	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—WNT1—osteoporosis	2.61e-05	0.00118	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TLN1—osteoporosis	2.59e-05	0.00118	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TLN1—osteoporosis	2.55e-05	0.00116	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGA—osteoporosis	2.53e-05	0.00115	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTHLH—osteoporosis	2.53e-05	0.00115	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—BMP2—osteoporosis	2.53e-05	0.00115	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—ADCY5—osteoporosis	2.5e-05	0.00113	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGB—osteoporosis	2.48e-05	0.00112	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CALCA—osteoporosis	2.44e-05	0.00111	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PSMA2—osteoporosis	2.39e-05	0.00108	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PSMA5—osteoporosis	2.39e-05	0.00108	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—POMC—osteoporosis	2.38e-05	0.00108	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BMP2—osteoporosis	2.36e-05	0.00107	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTHLH—osteoporosis	2.36e-05	0.00107	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGB—osteoporosis	2.31e-05	0.00105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—P4HB—osteoporosis	2.24e-05	0.00101	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CALCA—osteoporosis	2.23e-05	0.00101	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—IL6—osteoporosis	2.23e-05	0.00101	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PSMA2—osteoporosis	2.23e-05	0.00101	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PSMA5—osteoporosis	2.23e-05	0.00101	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KL—osteoporosis	2.22e-05	0.001	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—P4HB—osteoporosis	2.2e-05	0.000998	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTH—osteoporosis	2.18e-05	0.000986	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—POMC—osteoporosis	2.17e-05	0.000986	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—POMC—osteoporosis	2.16e-05	0.00098	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTH—osteoporosis	2.14e-05	0.000971	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RAP1A—osteoporosis	2.14e-05	0.000969	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CNR2—osteoporosis	2.12e-05	0.000961	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6R—osteoporosis	2.11e-05	0.000956	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—ADCY5—osteoporosis	2.11e-05	0.000954	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RAP1A—osteoporosis	2.1e-05	0.000954	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CNR2—osteoporosis	2.09e-05	0.000946	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NFATC1—osteoporosis	2.09e-05	0.000946	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.08e-05	0.000942	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CALCA—osteoporosis	2.07e-05	0.00094	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—ADCY5—osteoporosis	2.07e-05	0.000939	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—DKK1—osteoporosis	2.07e-05	0.000938	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NFATC1—osteoporosis	2.05e-05	0.000931	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DKK1—osteoporosis	2.04e-05	0.000923	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KL—osteoporosis	2.02e-05	0.000918	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—POMC—osteoporosis	2.02e-05	0.000917	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—WNT1—osteoporosis	1.99e-05	0.000904	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—POMC—osteoporosis	1.97e-05	0.000895	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—WNT1—osteoporosis	1.96e-05	0.000889	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGA—osteoporosis	1.94e-05	0.000879	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6R—osteoporosis	1.93e-05	0.000873	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—ADCY5—osteoporosis	1.91e-05	0.000866	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGA—osteoporosis	1.91e-05	0.000865	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KL—osteoporosis	1.88e-05	0.000854	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—ADCY5—osteoporosis	1.88e-05	0.000853	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—POMC—osteoporosis	1.84e-05	0.000833	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTHLH—osteoporosis	1.8e-05	0.000817	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BMP2—osteoporosis	1.8e-05	0.000817	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6R—osteoporosis	1.79e-05	0.000812	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTHLH—osteoporosis	1.77e-05	0.000804	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BMP2—osteoporosis	1.77e-05	0.000804	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGB—osteoporosis	1.76e-05	0.0008	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGB—osteoporosis	1.74e-05	0.000787	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ADCY5—osteoporosis	1.74e-05	0.000787	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PSMA2—osteoporosis	1.7e-05	0.000772	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PSMA5—osteoporosis	1.7e-05	0.000772	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SPP1—osteoporosis	1.68e-05	0.000761	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PSMA5—osteoporosis	1.68e-05	0.00076	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PSMA2—osteoporosis	1.68e-05	0.00076	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CALCA—osteoporosis	1.59e-05	0.00072	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADCY5—osteoporosis	1.59e-05	0.000719	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CALCA—osteoporosis	1.56e-05	0.000708	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—POMC—osteoporosis	1.55e-05	0.000702	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SPP1—osteoporosis	1.53e-05	0.000695	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—POMC—osteoporosis	1.52e-05	0.000691	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IRS2—osteoporosis	1.52e-05	0.000688	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—LEP—osteoporosis	1.49e-05	0.000674	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADCY5—osteoporosis	1.48e-05	0.000669	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KL—osteoporosis	1.44e-05	0.000653	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SPP1—osteoporosis	1.43e-05	0.000647	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000643	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KL—osteoporosis	1.42e-05	0.000643	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—POMC—osteoporosis	1.41e-05	0.000637	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IRS2—osteoporosis	1.39e-05	0.000629	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—POMC—osteoporosis	1.38e-05	0.000627	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6R—osteoporosis	1.37e-05	0.000622	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LEP—osteoporosis	1.36e-05	0.000616	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6R—osteoporosis	1.35e-05	0.000612	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IRS1—osteoporosis	1.33e-05	0.000601	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ESR1—osteoporosis	1.3e-05	0.000588	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IRS2—osteoporosis	1.29e-05	0.000585	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—POMC—osteoporosis	1.28e-05	0.000579	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LEP—osteoporosis	1.26e-05	0.000573	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6R—osteoporosis	1.25e-05	0.000564	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000557	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.21e-05	0.000549	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ESR1—osteoporosis	1.21e-05	0.000547	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—POMC—osteoporosis	1.17e-05	0.000529	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.14e-05	0.000516	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.13e-05	0.000512	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IRS1—osteoporosis	1.13e-05	0.000511	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.12e-05	0.000509	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.11e-05	0.000504	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SPP1—osteoporosis	1.09e-05	0.000495	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—POMC—osteoporosis	1.09e-05	0.000492	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.08e-05	0.000487	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6R—osteoporosis	1.06e-05	0.00048	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1—osteoporosis	1.04e-05	0.000473	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IRS2—osteoporosis	9.88e-06	0.000448	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IRS2—osteoporosis	9.72e-06	0.000441	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LEP—osteoporosis	9.67e-06	0.000438	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LEP—osteoporosis	9.51e-06	0.000431	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—osteoporosis	9.39e-06	0.000426	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ESR1—osteoporosis	9.23e-06	0.000418	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ESR1—osteoporosis	9.08e-06	0.000412	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IRS1—osteoporosis	8.63e-06	0.000391	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—osteoporosis	8.58e-06	0.000389	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IRS1—osteoporosis	8.49e-06	0.000385	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—POMC—osteoporosis	8.31e-06	0.000376	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—POMC—osteoporosis	8.17e-06	0.00037	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6R—osteoporosis	8.1e-06	0.000367	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1—osteoporosis	7.99e-06	0.000362	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—osteoporosis	7.99e-06	0.000362	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6R—osteoporosis	7.97e-06	0.000361	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1—osteoporosis	7.86e-06	0.000356	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—osteoporosis	7.38e-06	0.000334	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—osteoporosis	7.36e-06	0.000334	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—osteoporosis	6.74e-06	0.000306	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—osteoporosis	6.73e-06	0.000305	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—osteoporosis	6.28e-06	0.000284	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—osteoporosis	6.26e-06	0.000284	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—osteoporosis	6.11e-06	0.000277	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—osteoporosis	6.01e-06	0.000272	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—osteoporosis	5.55e-06	0.000251	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—osteoporosis	5.07e-06	0.00023	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—osteoporosis	4.8e-06	0.000218	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.79e-06	0.000217	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—osteoporosis	4.72e-06	0.000214	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—osteoporosis	4.72e-06	0.000214	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.71e-06	0.000214	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—osteoporosis	3.61e-06	0.000164	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—osteoporosis	3.55e-06	0.000161	CbGpPWpGaD
